15270203|t|A new Alzheimer's disease interventive strategy: GLP-1.
15270203|a|Glucagon-like peptide-1 (7-36)-amide (GLP-1) is an endogenous 30-amino acid gut peptide, which binds at the GLP-1 receptor coupled to the cyclic AMP second messenger pathway. GLP-1 receptor stimulation enhances pancreatic islet beta-cell proliferation, glucose-dependent insulin secretion and lowers blood glucose and food intake in patients with type 2 diabetes mellitus. Not limited to the pancreas, the chemoarchitecture of GLP-1 receptor distribution in the brain of rodents and humans correlates with a central role for GLP-1 in the regulation of food intake. However emerging evidence suggests that stimulation of neuronal GLP-1 receptors plays an important role in regulating neuronal plasticity and cell survival. GLP-1 has been documented to induce neurite outgrowth and to protect against excitotoxic cell death and oxidative injury in cultured neuronal cells. Moreover, GLP-1 and exendin-4, a naturally occurring more stable analogue of GLP-1 that likewise binds at the GLP-1 receptor, were shown to reduce endogenous levels of amyloid-beta peptide (Abeta) in mouse brain and to reduce levels of beta-amyloid precursor protein (betaAPP) in neurons. Collectively these data suggest that treatment with GLP-1 or a related peptide beneficially affects a number of the therapeutic targets associated with Alzheimer's disease (AD). Although much remains to be elucidated with regards to the downstream signaling pathways involved in the pro-survival properties of GLP-1, modulation of calcium homeostasis may be critical. This review will consider the potential therapeutic relevance of GLP-1 to CNS disorders, such as AD.
15270203	6	25	Alzheimer's disease	Disease	MESH:D000544
15270203	49	54	GLP-1	Gene	2740
15270203	94	99	GLP-1	Gene	2740
15270203	164	178	GLP-1 receptor	Gene	2740
15270203	194	204	cyclic AMP	Chemical	MESH:D000242
15270203	231	245	GLP-1 receptor	Gene	2740
15270203	309	316	glucose	Chemical	MESH:D005947
15270203	327	334	insulin	Gene	3630
15270203	362	369	glucose	Chemical	MESH:D005947
15270203	389	397	patients	Species	9606
15270203	403	427	type 2 diabetes mellitus	Disease	MESH:D003924
15270203	483	497	GLP-1 receptor	Gene	2740
15270203	539	545	humans	Species	9606
15270203	581	586	GLP-1	Gene	2740
15270203	778	783	GLP-1	Gene	2740
15270203	855	877	excitotoxic cell death	Disease	MESH:D003643
15270203	882	891	oxidative	Disease	MESH:D028361
15270203	937	942	GLP-1	Gene	14526
15270203	947	956	exendin-4	Chemical	MESH:D000077270
15270203	1004	1009	GLP-1	Gene	14526
15270203	1037	1051	GLP-1 receptor	Gene	14652
15270203	1117	1122	Abeta	Gene	11820
15270203	1127	1132	mouse	Species	10090
15270203	1163	1193	beta-amyloid precursor protein	Gene	11820
15270203	1195	1202	betaAPP	Gene	11820
15270203	1268	1273	GLP-1	Gene	2740
15270203	1368	1387	Alzheimer's disease	Disease	MESH:D000544
15270203	1389	1391	AD	Disease	MESH:D000544
15270203	1526	1531	GLP-1	Gene	2740
15270203	1547	1554	calcium	Chemical	MESH:D002118
15270203	1649	1654	GLP-1	Gene	2740
15270203	1658	1671	CNS disorders	Disease	MESH:D002494
15270203	1681	1683	AD	Disease	MESH:D000544
15270203	Association	MESH:D005947	MESH:D003924
15270203	Bind	14652	2740
15270203	Negative_Correlation	MESH:D003643	2740
15270203	Bind	14526	2740
15270203	Negative_Correlation	MESH:D028361	2740
15270203	Association	MESH:D000077270	14652
15270203	Association	MESH:D002494	2740
15270203	Bind	14526	14652
15270203	Negative_Correlation	MESH:D000077270	11820
15270203	Association	MESH:D000242	2740
15270203	Association	MESH:D005947	3630
15270203	Negative_Correlation	11820	14526
15270203	Association	MESH:D000544	2740
15270203	Positive_Correlation	2740	3630
15270203	Association	MESH:D003924	2740
15270203	Negative_Correlation	MESH:D005947	2740
15270203	Association	MESH:D002118	2740

